值得買(300785.SZ):消費類MCN業務簽約KOL數量達近250個,覆蓋粉絲量數量超4億
格隆匯4月18日丨值得買(300785.SZ)在4月14日15:00-16:00電話會議上表示,公司的消費類MCN業務通過旗下子公司多元通道開展,多元通道專注於垂直品類的消費內容,致力於在全網構建具有影響力的消費內容賬號矩陣,打造聚焦泛消費領域的MCN,簽約KOL數量達近250個,覆蓋粉絲量數量超4億。其中,公司內部孵化的IP賬號達到55個,矩陣全網總計粉絲量約2,700萬,賬號覆蓋數碼、個護、家居家電、藝術收藏、寵物、視頻、Z世代人羣等多個領域。2023年我們希望繼續增加孵化的自有賬號,同時簽約一些有影響力的外部賬號,增加在全域覆蓋的粉絲規模。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.